Lilly Articles

US PRICE MODERATION "VARIES BY COMPANY"

3 August 1992

LILLY SUES OVER CECLOR IN JAPAN

6 July 1992

DATABASE AFFIRMS THE SAFETY OF FLUVOXAMINE

6 July 1992

Tokyo: Stock Comment

6 July 1992

SCHERING FILES SUIT AGAINST GENENTECH

6 July 1992

US PHARMA INDEX LAUNCHED

29 June 1992

ISH REVIEWS POTASSIUM CHANNEL ACTIVATORS

29 June 1992

RESISTANCE ENSURES AUGMENTIN'S FUTURE

15 June 1992

ITALY'S RECORDATI LOOKS FOR EXPANSION

15 June 1992

Repligen and Lilly to cooperate

8 June 1992

HORMONE REPLACEMENT THERAPY: US REPORT

8 June 1992

ANALYSTS' CNS DRUGS COMMENTARY; USA

8 June 1992

US FDA INSPECTORS 'LACK NECESSARY POWERS"

1 June 1992

ELI LILLY: DES SETTLEMENT

25 May 1992

STOCK MARKET COMMENTARY: EUROPE

25 May 1992

US DRUG FIRMS' PUERTO RICO TAX CREDITS

25 May 1992

TREATING DIABETIC NEUROPATHY

18 May 1992

LILLY/BIOJECT DEAL

11 May 1992

STOCK MARKET COMMENTARY: NEW YORK

11 May 1992

STUDY SUPPORTS ULCER/H PYLORI HYPOTHESIS

11 May 1992

US COMPETITIVENESS IN JAPAN DRUG MARKET By P Reed Maurer

11 May 1992

BTG'S rhGH APPROVED IN FRANCE

27 April 1992

ELI LILLY BUYS STAKE IN BEIERSDORF GmbH

27 April 1992

GOOD SALES GROWTH FOR MAJOR US COS IN 1st QTR

27 April 1992

STOCK MARKET COMMENTARY: NEW YORK

13 April 1992

PROMISING ALZHEIMER'S PROGRAM FROM ATHENA

13 April 1992

DEPRESSION: THE COST TO SOCIETY

6 April 1992

DEPRESSION: THE COST TO SOCIETY

6 April 1992

US PRESCRIPTION PRICES UP 8.1%IN 1991

23 March 1992

STOCK MARKET COMMENTARY: NEW YORK

16 March 1992

FDA MOVE UPGRADES BIOCRAFT EARNINGS

9 March 1992

BIOCHEM PHARMA'S JOHN GILLARD

9 March 1992

US GENERIC DRUG MARKET TO 1995

17 February 1992

BIOCRAFT SETS SIGHTS ON GENERIC CECLOR

17 February 1992

NEW CHEMICAL ENTITIES UPDATE FOR 1991

10 February 1992

M&A IN JAPAN -- A PERSONAL PERSPECTIVE

3 February 1992

BULLETIN REVIEWS LILLY'S PROZAC

27 January 1992

ALZHEIMER'S DISEASE: US CONCERN

27 January 1992

REVISIONS FOR US ORPHAN DRUG ACT?

27 January 1992

DECEMBER US APPROS REVIEWED

20 January 1992

US FDA BEATS 1990 DRUG APPROVALS IN 1991

13 January 1992

DRUG FIRMS ARE STOCK MARKET DARLINGS

13 January 1992

KYOWA HAKKO TO EXPAND OVERSEAS

13 January 1992

STOCK MARKET COMMENTARY: NEW YORK

13 January 1992

LILLY INVESTING IN FRANCE

13 January 1992

SCIMED STOCK LEAP ON PRODUCT NEWS

13 January 1992

CELTRIX TO BECOME MAJOR BIOTECH PLAYER

13 January 1992

ANALGESICS IN THE USA -- AN OPEN DOOR FOR P&G?

6 January 1992

DRUG DISCOVERY IN JAPAN

6 January 1992

FEWER ACQUISITIONS AND MERGERS IN 1991

6 January 1992

ELI LILY EXPANDS IN FRANCE

6 January 1992

YEAR-END FDA APPROVALS

6 January 1992

US state praised for "leadership in biotech" by Eli Lilly chief